FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/24/2023
Back to search
Official data from USPTO
STANDARD LIPIDOCARE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
10/24/2023
Trademark type
Combined
Nice classes
5, 10
Filing date
11/11/2021
Registration date
06/27/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/27/2023
Last transaction
06/27/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
03
Owner location
KR
Examiner
KEELEY, ALISON REBECCA
Law office
M40
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the wording "STANDARD" in a stylized grey font with a grey line extending from the top of the "S", above the other letters, connecting to the top of the letter "D". The wording "LIPIDOCARE" appears below and to the right in a larger blue italicized font.
Holders and representatives
Holders
SD biosensor, Inc.
Representatives
Brian P. Gregg McNees Wallace & Nurick
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
chemical medical preparations for the diagnosis of diabetes; diagnostic agents for pharmaceutical use; diagnostic preparations for medical or veterinary purposes; diagnostic reagents for medical or veterinary purposes; reagents and media for medical and veterinary diagnostic purposes; diagnostic preparations for medical and veterinary use; medical diagnostic test strips for blood analysis; reagents for use in diagnostic tests for medical purposes; medical diagnostic reagents; diagnostic preparations for medical purposes; diagnostic chemical reagents for medical use; in vitro diagnostic preparations for medical purposes; reactants for medical diagnosis; indicators in the nature of chemical preparations for medical diagnosis; diagnostic reagents for clinical medical use; chemical preparations for the diagnosis of pregnancy; diagnostic biomarker reagents for medical purposes; pharmaceutical preparations for diagnosis
Class 10
Medical apparatus for automatic diagnosis of tuberculosis; medical diagnostic measuring apparatus for medical use for analyzing blood; apparatus for carrying-out diagnostic tests for medical purposes for analyzing blood; diagnostic apparatus for medical purposes for analyzing blood; medical apparatus and instruments in the fields of clinical diagnosis for analyzing blood; diagnosticexaminationmonitoring equipmentblood sugar or cholesterol monitors; testing instruments for medical diagnostic purposes for analyzing blood; tools for medical diagnostics for analyzing blood; testing probes for medical diagnostic purposes for analyzing blood; in vitro diagnostic devices for medical purposes for analyzing blood
Publications
History of USPTO decisions and trademark events.
25 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/29/2023
FIMP
FINAL DISPOSITION PROCESSED
09/29/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/27/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/27/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
06/27/2023
GPNX
NOTIFICATION PROCESSED BY IB
04/25/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/11/2023
PUBO
PUBLISHED FOR OPPOSITION
04/11/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/05/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/05/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/22/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/09/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/07/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/07/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/07/2023
RFNP
REFUSAL PROCESSED BY IB
11/08/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/20/2022
RFRR
REFUSAL PROCESSED BY MPU
10/19/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/27/2022
CNRT
NON-FINAL ACTION WRITTEN
08/26/2022
DOCK
ASSIGNED TO EXAMINER
08/23/2022
MAFR
APPLICATION FILING RECEIPT MAILED
03/22/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/17/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/10/2022
Continuous trademark protection
Get notified about every new filing that threatens STANDARD LIPIDOCARE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.